AMGN Amgen: submits data to FDA seeking hearing on tavneos avacopan in response to withdrawal proposal Amgen Inc: strongly disagrees with FD

AMGN Amgen: submits data to FDA seeking hearing on tavneos avacopan in response to withdrawal proposal Amgen Inc: strongly disagrees with FDA's proposal to withdraw tavneos from the U.S. market